Gerard J. Meskill, MD is board certified in both neurology and sleep medicine, and he is the founder and CEO of Tricoastal Narcolepsy and Sleep Disorders Center. The "Tricoastal" moniker references his background: he completed neurology residency on the East Coast at Long Island Jewish Medical Center – where he served as chief resident, sleep fellowship on the West Coast at Stanford University, and he now practices sleep medicine and neurology on the Gulf Coast in the greater Houston, Texas area. In the sleep world, he is known for expertise in the treatment of narcolepsy, obstructive sleep apnea (OSA), and insomnia. He is published in peer-reviewed journals and texts, as well as online media. He has served as principal investigator in clinical research trials focused on narcolepsy and OSA. He regularly serves on narcolepsy treatment advisory boards and founded A.W.A.K.E. Greater Houston, a support group for individuals afflicted with narcolepsy and other sleep disorders that works in partnership with the Narcolepsy Network and the American Sleep Apnea Association. He has been recognized by Texas Monthly magazine as one of Texas’s Super Doctors Rising Stars (2018-22). Dr. Meskill’s professional passion is to improve the lives of patients suffering from disorders of central hypersomnia, such as narcolepsy and idiopathic hypersomnia. From 2019-20, he was the principal investigator of the Houston arm of the Pitolisant Expanded Access Clinical Evaluation (PEACE) program.